Proof-of-Concept Interventional Study With a Nasal Spray of JT-1 in Patients With Chronic Rhinitis or Chronic Sinusitis

NCT05331222 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

3

Enrollment

INDUSTRY

Sponsor class

Stopped regulatory issues

Conditions

Chronic Rhinitis
Chronic Sinus Congestion

Interventions

DRUG: JT-1

Sponsor

Jantar GmbH